Articles sélectionnés

DÉPARTEMENT DE MÉDECINE - HÔPITAL GÉNÉRAL JUIF

PUBLICATIONS (January – December 2016)

Afilalo, Jonathan

--Drudi LM, Phung K, Ades M, Zuckerman J, Mullie L, Steinmetz OK, Obrand DI, Afilalo J. Psoas Muscle Area Predicts All-Cause Mortality After Endovascular and Open Aortic Aneurysm Repair. Eur J Vasc Endovasc Surg, 2016 Dec;52(6):764-769

--Hummel SL, Alpert CM, Galatas C, Afilalo J. Training Geriatric Cardiologists for an Aging Population: Time to Get Going. Am J Med. 2016 Nov 25. Epub ahead of print

--Zuckerman J, Ades M, Mullie L, Trnkus A, Morin JF, Langlois Y, Ma F, Levental M, Morais JA, Afilalo J. Psoas Muscle Area and Length of Stay in Older Adults Undergoing Cardiac Surgery. Ann Thorac Surg. 2016 Nov 15;223:736-743

--Ferrara F, Rudski LG, Vriz O, Gargani L, Afilalo J, D'Andrea A, D'Alto M, Marra AM, Acri E, Stanziola AA, Ghio S, Cittadini A, Naeije R, Bossone E. Physiologic correlates of tricuspid annular plane systolic excursion in 1168 healthy subjects. Int J Cardiol. 2016 Aug 18;223:736-743

--Arnold SV, Afilalo J, Spertus JA, Tang Y, Baron SJ, Jones PG, Reardon MJ, Yakubov SJ, Adams DH, Cohen DJ; U.S. CoreValve Investigators. Prediction of Poor Outcome after Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 Oct 25;68(17):1868-1877

--Afilalo J. Conceptual Models of Frailty: The Sarcopenia Phenotype. Can J Cardiol. 2016 Sep;32(9):1051-5

--Hermiller JB Jr, Yakubov SJ, Reardon MJ, Deeb GM, Adams DH, Afilalo J, Huang J, Popma JJ; CoreValve United States Clinical Investigators. Predicting Early and Late Mortality After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2016 Jul 26;68(4):343-52

--Afilalo J, Steele R, Manning WJ, Khabbaz KR, Rudski LG, Langlois Y, Morin JF, Picard MH. Derivation and Validation of Prognosis-Based Age Cutoffs to Define Elderly in Cardiac Surgery. Circ Cardiovasc Qual Outcomes. 2016 Jul;9(4):424-31

--Afilalo J, Kim S, O'Brien S, Brennan JM, Edwards FH, Mack MJ, McClurken JB, Cleveland JC Jr, Smith PK, Shahian DM, Alexander KP. Gait Speed and Operative Mortality in Older Adults Following Cardiac Surgery. JAMA Cardiol. 2016 Jun 1;1(3):314-21

--Bibas L, Levi M, Touchette J, Mardigyan V, Bernier M, Essebag V, Afilalo J. Implications of Frailty in Elderly Patients With Electrophysiological Conditions. JACC EP. 2016;2(3):288-294. Epub

--Afilalo J. The Road the Frailty Is Paved With Good Intentions. Circ Cardiovasc Qual Outcomes. 2016 May;9(3):194-6

--Alfredsson J, Stebbins A, Brennan JM, Matsouaka R, Afilalo J, Peterson ED, Vemulapalli S, Rumsfeld JS, Shahian D, Mack MJ, Alexander KP. Gait Speed Predicts 30-Day Mortality Following Transcatheter Aortic Valve Replacement: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Circulation. 2016 Apr 5;133(14):1351-9

--Senaratne JM, Norris CM, Graham MM, Galbraith D, Nagendran J, Freed DH, Afilalo J, Van Diepen S; APPROACH Investigators. Clinical and angiographic outcomes associated with surgical revascularization of angiographically borderline 50-69% coronary artery stenoses. Eur J Cardiothorac Surg. 2016 May;49(5):e112-8

--Mamane S, Mullie L, Piazza N, Martucci G, Morais J, Vigano A, Levental M, Nelson K, Lange R, Afilalo J. Psoas Muscle Area and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The Montreal-Munich Study. Can J Cardiol. 2016 Feb;32(2):177-82. Epub 2015 Dec 9

Agulnik, Jason

--Hanna NH, Kaiser R, Sullivan RN, Aren OR, Ahn MJ, Tiangco B, Voccia I, Pawel JV, Kovcin V, Agulnik J,Gaschler-Markefski B, Barrueco J, Sikken P, Schloss C, Kim JH; LUME-Lung 2 Study group. Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial. Lung Cancer. 2016 Dec;102:65-73

--Melosky B, Agulnik J, Albadine R, Banerji S, Bebb DG, Bethune D, Blais N, Butts C, Cheema P, Cheung P, Cohen V, Deschenes J, Ionescu DN, Juergens R, Kamel-Reid S, Laurie SA, Liu G, Morzycki W, Tsao MS, Xu Z, Hirsh V. Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer. Curr Oncol. 2016 Jun;23(3):196-200

Alaoui-Jamali, Moulay

--Saad A, Bijian K, Qiu D, da Silva SD, Marques M, Chang CH, Nassour H, Ramotar D, Damaraju S, Mackey J, Bismar T, Witcher M, Alaoui-Jamali MA. Insights into a novel nuclear function for Fascin in the regulation of the amino-acid transporter SLC3A2. Sci Rep. 2016 Nov 7;6:36699

--Nassour H, Wang Z, Saad A, Papaluca A, Brosseau N, Affar el B, Alaoui-Jamali MA, Ramotar D. Peroxiredoxin 1 interacts with and blocks the redox factor APE1 from activating interleukin-8 expression. Sci Rep. 2016 Jul 8;6:29389

--Bakkar A, Alshalalfa M, Petersen LF, Abou-Ouf H, Al-Mami A, Hegazy SA, Feng F, Alhajj R, Bijian K, Alaoui-Jamali MA, Bismar TA. microRNA 338-3p exhibits tumor suppressor role and its down-regulation is associated with adverse clinical outcome in prostate cancer patients. Mol Biol Rep. 2016 Apr;43(4):229-40

--Alaoui-Jamali MA, Wurzba SD, and Bijian K. K. Diversity of growth factor-regulated kinases involved in the DNA damage response and implication for drug resistance. In: DNA Repair in Cancer Therapy, Edited by Mark Kelley and Melissa Fisher, Elsevier Inc., Waltham, MA, 2016

--Kahouli I, Malhotra M, Westfall S, Alaoui-Jamali MA, Prakash S. Design and validation of an orally administrated active L. fermentum-L. acidophilus probiotic formulation using colorectal cancer Apc Min/+ mouse model. Appl Microbiol Biotechnol. 2016 Mar;101:1999-2019

Assouline, Sarit

--MacDonald D, Prica A., Assouline S, Christofides A, Lawrence T, Sehn LH. Emerging therapies for the treatment of relapsed or refractory follicular lymphoma. Curr Oncol. 2016 Dec;23(6):407-17

--Damlaj M, Lipton JH, Assouline S. A safety evaluation of omacetaxine mepesuccinate for the treatment of chronic myeloid leukemia. Expert Opin Drug Saf. 2016:1279-86

--Engel NW, Constantin A, Fowlkes S, Assouline S. Unexpected Success of Watch and Wait Strategy in a Ponatinib-Intolerant Patient With Chronic Myeloid Leukemia. J Oncol Pract. 2016, 12:592-4

--Dupéré-Richer D, Kinal M, Pettersson F, Emond A, Calvo-Vidal MN, Nichol JN, Guilbert C, Plourde D, Klein Oros K, Nielsen TH, Ezponda T, Licht JD, Johnson NA, Assouline S, Cerchietti L, Miller WH Jr, Mann KK. Increased protein processing gene signature in HDACi-resistant cells predicts response to proteasome inhibitors. Leuk Lymphoma. 2017, 58:218-221. (E-pub Mai 17, 2016)

--Assouline SE, Nielsen TH, Yu S, Alcaide M, Chong L, MacDonald D, Tosikyan A, Kukreti V, Kezouh A, Petrogiannis-Haliotis T, Albuquerque M, Fornika D, Alamouti S, Froment R, Greenwood CM, Oros KK, Camglioglu E, Sharma A, Christodoulopoulos R, Rousseau C, Johnson N, Crump M, Morin RD, Mann KK. Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma. Blood. 2016, 128:185-94. (Manuscript with Editorial Comment)

--Lipton JH, Chuah C, Guerci-Bresler A, Rosti G, Simpson D, Assouline S, Etienne G, Nicolini FE, le Coutre P, Clark RE, Stenke L L, Andorsky D, Oehler V, Lustgarten S, Rivera VM, Clackson T, Haluska FG, Baccarani M, Cortes JE, Guilhot F, Hochhaus A, Hughes T, Kantarjian HM, Shah NP, Talpaz M, Deininger MW; EPIC investigators. Ponatinib versus imatinib for newly diagnosed chronic myeloid leukemia: an international, randomised, open-label, phase 3 trial. Lancet Oncol. 2016, 17:612-21

--Assouline S, Buccheri V, Delmer A, Gaidano G, Trneny M, Berthillon N, Brewster M, Catalani O, Li S, McIntyre C, Sayyed P, Badoux X. Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial. Lancet Haematol. 2016, 3:e128-38

--Reis B, Jukofsky L, Chen G, Martinelli G, Zhong H, So WV, Dickinson MJ, Drummond M, Assouline S, Hashemyan M, Theron M, Blotner S, Lee JH, Kasner M, Yoon SS, Rueger R, Seiter K, Middleton SA, Kelly KR, Vey N, Yee K, Nichols G, Chen LC, Pierceall WE. Acute myeloid leukemia patients' clinical response to idasanutlin (RG7388) is associated with pre-treatment MDM2 protein expression in leukemic blasts. Haematologica. 2016, 101:e185-8

Autexier, Chantal

--Rousseau P, Khondaker S, Zhu S, Lauzon C, Mai S, and Autexier C. 2016. An intact putative mouse telomerase essential N-terminal (TEN) domain is necessary for proper telomere maintenance. Biology of the Cell, 108, 96-112. Epub 2016 Feb 18

--Chu TW, MacNeil D. and Autexier C. 2016. Multiple mechanisms contribute to the cell growth defects imparted by human telomerase insertion in finger domain mutations associated with premature aging diseases. Journal of Biological Chemistry, 291, 8374-8386. Epub 2016 Feb 17

--Chu TW and Autexier C. Telomeres and chromosome stability. 2016. In: The Functional Nucleus. Bazett-Jones DP and Dellaire G, eds. Springer DE Publishers

--MacNeil DE, Bensoussan HJ and Autexier C. 2016. Telomerase Regulation from Beginning to the End. Genes, 7, 1-33

Baron, Murray

--Baron M, Pope J, Robinson D, Jones N, Khalidi N, Docherty P, Kaminska E, Masetto A, Sutton E, Mathieu JP, Ligier S, Grodzicky T, Leclercq S, Thorne C, Gyger G, Smith D, Fortin PR, Larche M, Abu-Hakima M, Rodriguez-Reyna TS, Cabral-Castaneda AR, Fritzler MJ, Wang M, Hudson M. Calcinosis is associated with digital ischaemia in systemic sclerosis-a longitudinal study. Rheumatology (Oxford, England) 2016;55:2148-55

--Wu M, Assassi S, Salazar GA, Pedroza C, Gorlova OY, Chen WV, Charles J, Taing ML, Liao K, Wigley FM, Hummers LK, Shah AA, Hinchcliff M, Khanna D, Schiopu E, Phillips K, Furst DE, Steen V, Baron M, Hudson M, Zhou X, Pope J, Jones N, Docherty P, Khalidi NA, Robinson D, Simms RW, Silver RM, Frech TM, Fessler BJ, Fritzler MJ, Molitor JA, Segal BM, Movahedian M, Martin J, Varga J, Mayes MD. Genetic susceptibility loci of idiopathic interstitial pneumonia do not represent risk for systemic sclerosis: a case control study in Caucasian patients. Arthritis research & therapy 2016;18:20

--Riehm KE, Kwakkenbos L, Carrier ME, Bartlett SJ, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Nielsen K, Baron M, Frech T, Hudson M, Pope J, Sauve M, Suarez-Almazor ME, Wigley FM, Thombs BD. Validation of the Self-Efficacy for Managing Chronic Disease Scale: A Scleroderma Patient-Centered Intervention Network Cohort Study. Arthritis care & research 2016;68:1195-200

--Baron M, Hudson M, Dagenais M, Macdonald D, Gyger G, El Sayegh T, Pope J, Fontaine A, Masetto A, Matthews D, Sutton E, Thie N, Jones N, Copete M, Kolbinson D, Markland J, Nogueira-Filho G, Robinson D, Fritzler M, Wang M, Gornitsky M. Relationship Between Disease Characteristics and Oral Radiologic Findings in Systemic Sclerosis: Results From a Canadian Oral Health Study. Arthritis care & research 2016;68:673-80

--Baron M. Targeted Therapy in Systemic Sclerosis. Rambam Maimonides medical journal 2016;7(4): e0030 doi: 10.5041/RMMJ.10257

--Khanna D, Berrocal VJ, Giannini EH, Seibold JR, Merkel PA, Mayes MD, Baron M, Clements PJ, Steen V, Assassi S, Schiopu E, Phillips K, Simms RW, Allanore Y, Denton CP, Distler O, Johnson SR, Matucci-Cerinic M, Pope JE, Proudman SM, Siegel J, Wong WK, Wells AU, Furst DE. The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis. Arthritis & rheumatology (Hoboken, NJ) 2016;68:299-311

--Khanna D, Denton CP, Jahreis A, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Pope JE, Riemekasten G, Steen V, Muller-Ladner U, Lafyatis R, Stifano G G, Spotswood H, Chen-Harris H, Dziadek S, Morimoto A, Sornasse T, Siegel J, Furst DE. Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial. Lancet (London, England) 2016

--Morardet L, Avouac J, Sammour M, Baron M, Kahan A, Feydy A, Allanore Y. Late Nailfold Videocapillaroscopy Pattern Associated With Hand Calcinosis and Acro-Osteolysis in Systemic Sclerosis. Arthritis care & research 2016;68:366-73

--Nevskaya T, Baron M, Pope JE. European scleroderma study group activity index captures variations in disease activity over time and predicts organ damage in early systemic sclerosis: Data from the Canadian scleroderma research group. Annals of the Rheumatic Diseases 2016;75:65-6

--Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirjak L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, Muller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y. The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Annals of the rheumatic diseases 2016

--Valenzuela A, Baron M, Herrick AL, Proudman S, Stevens W, Rodriguez-Reyna TS, -Vacca A, Medsger TA, Jr., Hinchcliff M, Hsu V, Wu JY, Fiorentino D, Chung L. Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study. Seminars in arthritis and rheumatism 2016

--Tay T, Ferdowsi N, Baron M, Stevens W, Hudson M, Proudman SM, Nikpour M. Measures of disease status in systemic sclerosis: A systematic review. Seminars in arthritis and rheumatism 2016

Bergman, Howard

--Farcet A, De Decker L, Pauly V, Rousseau F, Bergman H, Molines C, Retornaz F. Frailty markers and treatment decisions in patients seen in onco-geriatric clinics: results from the ASRO Pilot study. PLoS One. 2016 Feb 26;11(2):e0149732. doi: 10.1371/journal.pone.0149732. eCollection2016

--Puts M, Toubasi S, Atkinson E, Ayala A, Andrew M, Ashe M, Bergman H, Ploeg J, McGilton K. Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a protocol for a scoping review of the literature and international policies. BMJ Open. 2016 Mar 2;6(3):e010959. doi: 10.1136/bmjopen-2015-010959

Blostein, Mark

--Aghourian MN, Lemarié CA, Bertin FR, Blostein MD. Prostaglandin E synthase is upregulated by Gas6 during cancer-induced venous thrombosis. Blood. 2016 Feb 11;127(6):769-77 (Manuscript with Editorial Comment)

--Douketis JD, Wang G, Chan N, Eikelboom JW, Syed S, Barty R, Moffat KA, Spencer FA, Blostein M, Schulman S. Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure. J Thromb Haemost. 2016 Jan;14(1):89-97

--Connolly SJ, Milling TJ Jr, Eikelboom JW, Gibson CM, Curnutte JT, Gold A, Bronson MD, Lu G, Conley PB, Verhamme P, Schmidt J, Middeldorp S, Cohen AT, Beyer-Westendorf J, Albaladejo P, Lopez-Sendon J, Goodman S, Leeds J, Wiens BL, Siegal DM, Zotova E, Meeks B, Nakamya J, Lim WT, Crowther M; ANNEXA-4 Investigators*. Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors. N Engl J Med. 2016, 375:1131-41. *M Blostein Local site investigator

--Ma K, Wells P, Guzman C, Anderson D, Blostein M, Hirsch A, Lazo-Langner A, Kovacs MJ, Rodger M, Tagalakis V, Kahn SR. A multicenter prospective study of risk factors and treatment of unusual site thrombosis. Thromb Res. 2016, 144:100-5

--*Rahmani PA, *Guzman C, Kezouh A, Blostein M, M, Kahn S. Association between patient knowledge of anticoagulation, INR control and warfarin-related adverse events. Journal of Pharmacy Technology August 2016;32(4):150-159

Borchers, Christoph

--Baker TC, Han J, Borchers CH. Recent advancements in matrix-assisted laser desorption/ionization mass spectrometry imaging. Curr Opin Biotechnol. 2016 Sep; 27;43:62-69. doi: 10.1016/j.copbio.2016.09.003. [Epub ahead of print]

--Bautista-López NL, Ndao M, Camargo FV, Nara T, Annoura T, Hardie DB, Borchers CH, Jardim A. Characterization and diagnostic application of Trypanosoma cruzi trypomastigote excreted-secreted antigens shed in extracellular vesicles released from infected mammalian cells. J Clin Microbiol. 2016 Dec; 14. pii: JCM.01649-16. [Epub ahead of print]

--Borchers C, Thibault P. Introduction to the HUPO 2015 Special Issue. J Proteomics. 2016 Oct; 21;(149):1-2. doi: 10.1016/j.jprot.2016.09.013

--Bround MJ, Wambolt R, Cen H, Asghari P, Albu RF, Han J, McAfee D, Pourrier M, Scott NE, Bohunek L, Kulpa JE, Chen SW, Fedida D, Brownsey RW, Borchers CH, Foster LJ, Mayor T, Moore ED, Allard MF, Johnson JD. Ryr2-Mediated Calcium Signals Specifically Promote Glucose Oxidation via Pyruvate Dehydrogenase. J Biol Chem. 2016 Sep 12. pii: jbc.M116.756973. [Epub ahead of print]

--Groitl B, Horowitz S, Makepeace KA, Petrotchenko EV, Borchers CH, Reichmann D, Bardwell JC, Jakob U. Protein unfolding as a switch from self-recognition to high-affinity client binding. Nat Commun. 2016 Jan; 20(7):10357. doi: 10.1038/ncomms10357

--Han J, Yi Y, Lin K, Birks SJ, Gibson JJ, Borchers CH. Molecular profiling of naphthenic acids in technical mixtures and oil sands process-affected water using polar reversed-phase liquid chromatography-mass spectrometry. Electrophoresis. 2016 Sep 26; doi: 10.1002/elps.201600250. [Epub ahead of print]

--Han J, Lin K, Sequria C, Yang J, Borchers CH. Quantitation of low molecular weight sugars by chemical derivatization-liquid chromatography/multiple-reaction monitoring/mass spectrometry. Electrophoresis. 2016 Apr; 27. doi: 10.1002/elps.201600150. [Epub ahead of print]

--Jingxi Pan, Suping Zhang, Albert Chou, Christoph H. Borchers. Higher-order structural interrogation of antibodies using middle-down hydrogen/deuterium exchange mass spectrometry. Chem. Sci., Issue 2, 2016, DOI: 10.1039/C5SC03420E

--Leung JM, Chen V, Hollander Z, Dai D, Tebbutt SJ, Aaron SD, Vandemheen KL, Rennard SI, FitzGerald JM, Woodruff PG, Lazarus SC, Connett JE, Coxson HO, Miller B, Borchers C, McManus BM, Ng RT, Sin DD. COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry. PLoS One. 2016 Aug; 15;11(8):e0161129. doi: 10.1371/journal.pone.0161129. eCollection 2016

--Mohammed Y, Bhowmick P, Smith DS, Domanski D, Jackson AM, Michaud SA, Malchow S, Percy AJ, Chambers AG, Palmer A, Zhang S, Sickmann A, Borchers CH. PeptideTracker: A knowledgebase for collecting and storing information on protein concentrations in biological tissues. Proteomics. 2016 Sep; 29. doi: 10.1002/pmic.201600210. [Epub ahead of print]

--Pan J, Zhang S, Borchers CH. Protein species-specific characterization of conformational change induced by multisite phosphorylation. J J Proteomics. 2016 Feb 16;134:138-43. doi: 10.1016/j.jprot.2015.12.002. Epub 2015 Dec 7

--Pan J, Zhang S, Borchers CH. Comparative higher-order structure analysis of antibody biosimilars using combined bottom-up and top-down hydrogen-deuterium exchange mass spectrometry. Biochim Biophys Acta. 2016 Aug 25. pii: S1570-9639(16)30169-8. doi:10.1016/j.bbapap.2016.08.013. [Epub ahead of print]

--Percy AJ, Yang J, Chambers AG, Borchers CH. Increased Depth and Breadth of Plasma Protein Quantitation via Two-Dimensional Liquid Chromatography/Multiple Reaction Monitoring-Mass Spectrometry with Labeled Peptide Standards. Methods Mol Biol. 2016;1410:1-21. doi: 10.1007/978-1-4939-3524-6_1

--Percy AJ, Michaud SA, Jardim A, Sinclair NJ, Zhang S, Mohammed Y, Palmer AL, Hardie DB, Yang J, Leblanc AM, Borchers CH. Multiplexed MRM-based assays for the quantitation of proteins in mouse plasma and heart tissue. Proteomics. 2016 Sep;30. doi: 10.1002/pmic.201600097. [Epub ahead of print]

--Brodie NI, Petrotchenko EV, Borchers CH. The novel isotopically coded short-range photo-reactive crosslinker 2,4,6-triazido--1,3,5-triazine (TATA) for studying protein structures. J Proteomics. 2016 Feb; 27. pii: S1874-3919(16)30046-X. doi: 10.1016/j.jprot.2016.02.024. [Epub ahead of print]

--Percy AJ, Hardie DB, Jardim A, Yang J, Elliott MH, Zhang S, Borchers CH. Multiplexed panel of precisely quantified salivary proteins for biomarker assessment. Proteomics. 2016 Aug; 19. doi: 10.1002/pmic.201600230. [Epub ahead of print]

--Qiu YL, Gong JY, Feng JY, Wang RX, Han J, Liu T, Lu Y, Li LT, Zhang MH, Sheps JA, Wang NL, Yan YY, Li JQ, Chen L, Borchers CH, Sipos B, Knisely AS, Ling V, Xing QH, Wang JS. Defects in MYO5B are associated with a spectrum of previously undiagnosed low?-glutamyltransferase cholestasis. Hepatology, 2016 Dec; 27. doi: 10.1002/hep.29020. [Epub ahead of print]

--Sobsey CA, Han J, Lin K, Swardfager W, Levitt A, Borchers CH. Development and evaluation of a liquid chromatography-mass spectrometry method for rapid, accurate quantitation of malondialdehyde in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jul 7;1029-1030:205-212. doi: 10.1016/j.jchromb.2016.07.013. [Epub ahead of print]

--Szabat M, Page MM, Panzhinskiy E, Skovsø S, Mojibian M, Fernandez-Tajes J, Bruin JE, Bround MJ, Lee JT, Xu EE, Taghizadeh F, O'Dwyer S, van de Bunt M, Moon KM, Sinha S, Han J, Fan Y, Lynn FC, Trucco M, Borchers CH, Foster LJ, Nislow C, Kieffer TJ, Johnson JD. Reduced Insulin Production Relieves Endoplasmic Reticulum Stress and Induces ß Cell Proliferation. Cell Metab. 2016 Jan; 12 (23)(1):179-93. doi: 10.1016/j.cmet.2015.10.016. Epub 2015 Nov 25

--Wang X, Han J, Hardie DB, Yang J, Borchers CH. The use of matrix coating assisted by an electric field (MCAEF) to enhance mass spectrometric imaging of human prostate cancer biomarkers. J Mass Spectrom. 2016 Jan;51(1):86-95. doi: 10.1002/jms.3728

--Wang X, Han J, Hardie DB, Yang J, Pan J, Borchers CH. Metabolomic profiling of prostate cancer by matrix assisted laser desorption/ionization-Fourier transform ion cyclotron resonance mass spectrometry imaging using Matrix Coating Assisted by an Electric Field (MCAEF). Biochim Biophys Acta, 2016 Dec; 22. pii: S1570-9639(16)30277-1.doi: 10.1016/j.bbapap.2016.12.012 [Epub ahead of print]

--Yang J, Finke JC, Yang J, Percy AJ, von Fritschen U, Borchers CH, Glocker MO. Early risk prognosis of free-flap transplant failure by quantitation of the macrophage colony-stimulating factor in pa

Dernière modification de la page le 

Nous recherchons toujours des commentaires pour améliorer notre site.